RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • U.S., Canada allow emergency use of Tekmira's Ebola treatment

    U.S., Canada allow emergency use of Tekmira's Ebola treatment
    (Reuters) - Canadian drugmaker Tekmira Pharmaceuticals Corp said on Monday that U.S. and Canadian regulators have authorized the use of its Ebola treatment in patients who have confirmed or suspected infections from the deadly virus. The Vancouver-...
  • Germany's Merck to buy Sigma-Aldrich for $17 billion to boost lab supplies operation

    FRANKFURT (Reuters) - Drugs and chemicals maker Merck KGaA agreed on Monday to acquire U.S.-based Sigma-Aldrich Corp for $17 billion in cash to boost its lab supplies business, the biggest takeover in the German group's history. The deal helps Merck,...
  • After China, GlaxoSmithKline faces pressure for change

    LONDON (Reuters) - GlaxoSmithKline may have closed one chapter in a saga of corruption allegations by accepting a $489 million fine in China, but the drugmaker has its work cut out to win back skeptical investors. That means continued pressure on Chief...
  • ValueAct returns to Valeant board, plans to raise stake

    (Reuters) - Hedge fund ValueAct Capital said on Thursday it would return to the board of directors of Valeant Pharmaceuticals International Inc, which is pursuing a hostile takeover offer for Allergan Inc, and that it planned to increase its stake in...
  • Horizon Pharma defies lawmakers, moves to Ireland

    Horizon Pharma defies lawmakers, moves to Ireland
    Despite growing criticism from lawmakers in Washington, a Deerfield drugmaker on Friday officially planted its corporate flag in Ireland, a move designed in part to lower its tax bill. Horizon Pharma completed its $587 million acquisition of the Irish...
  • Valeant CEO expects quarterly profit to exceed forecast

    (Reuters) - Valeant Pharmaceuticals Inc expects third-quarter revenue to beat analyst expectations and adjusted earnings per share to surpass the company's forecast, its CEO said on Wednesday, seeking to bolster a hostile takeover bid for Allergan Inc...
  • U.S. doctor was treated with experimental Ebola drug TKM-Ebola

    U.S. doctor was treated with experimental Ebola drug TKM-Ebola
    An American doctor who is recovering from Ebola at a Nebraska hospital got an experimental Canadian drug as part of his treatment, hospital officials disclosed this week. Dr. Rick Sacra started receiving TKM-Ebola, manufactured by Canadian drug firm ...
  • AbbVie shares drop as tax rules cloud Shire deal

    AbbVie shares drop as tax rules cloud Shire deal
    Shares in North Chicago-based AbbVie and other drugmakers fell Tuesday after the Obama administration this week issued a string of new rules to crack down on U.S. companies that seek to cut their tax bills by moving their addresses abroad. AbbVie shares...
  • GlaxoSmithKline appoints RBS's Hampton as next chairman

    LONDON (Reuters) - Drugmaker GlaxoSmithKline confirmed on Thursday it had chosen Philip Hampton, who currently chairs Royal Bank of Scotland , as its next chairman. Hampton will take the helm at Britain's top pharmaceuticals group at a testing time....
  • Nicox gets boost from strong prospects for glaucoma drug

    PARIS (Reuters) - French pharmaceutical firm Nicox unveiled positive Phase III results for its glaucoma drug on Thursday and said, if approved by regulators, the product could reach peak annual sales of over $1 billion worldwide. Shares in the company...
  • AstraZeneca, Shire dive as U.S. tax move punctures deal hopes

    LONDON (Reuters) - Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. Treasury took steps to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad. The move could jeopardize an...